CXCR2 and amyotrophic lateral sclerosis: Although further studies are still necessary to completely elucidate the contribution of CXCR2/ligands in ALS pathogenesis and to define the impact of this signaling pathway in motor neuronal selective degeneration, our data further support a role of this axis in ALS pathogenesis and confirm its pharmacological modulation as a candidate therapeutic strategy against ALS.